Gary S. Gillheeney, President and CEO at Organogenesis Holdings Inc. (ORGO), sold 527,378 shares at $5.94 ($3.0M) on 2022-05-19, disclosed to the SEC on 2022-05-20.
Open-market sale of $3.0M ORGO by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.46 | 86,531 | $472K | 15.5% |
| 2 | $5.46 | 86,531 | $472K | 15.5% |
| 3 | $5.94 | 118,504 | $704K | 23.1% |
| 4 | $5.94 | 118,504 | $704K | 23.1% |
| 5 | $5.89 | 58,654 | $345K | 11.4% |
| 6 | $5.89 | 58,654 |
| $345K |
| 11.4% |
| Total | $5.77 avg | 527,378 | $3.0M | 100% |
| Filing → |
| ORGO | SELL | 2024-12-09 | $423K | — | Filing → |
| ORGO | SELL | 2022-06-03 | $2.7M | — | Filing → |
| ORGO | SELL | 2022-05-31 | $2.6M | — | Filing → |